BriaCell Therapeutics Corp. (BCTX) Research & Development (2021 - 2026)
BriaCell Therapeutics (BCTX) posted Research & Development of $6.0 million for Q2 2026, down 1.44% sequentially from $6.1 million in Q1 2026, and up 24.04% YoY from $4.8 million in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Research & Development (2021 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Research & Development for 6 years, with the latest figure at $6.0 million in Q2 2026.
- Quarterly Research & Development rose 24.04% year-over-year to $6.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $25.8 million (up 39.04% YoY) and the FY2025 annual result came in at $21.3 million, down 21.74% from the prior year.
- Research & Development retreated to $6.0 million in Q2 2026 per BCTX's latest filing, from $6.1 million in the prior quarter.
- Over five years, Research & Development peaked at $8.3 million in Q1 2024 and troughed at $1.7 million in Q1 2022.
- A 5-year average of $5.0 million and a median of $5.0 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 931.56% in 2022, then slumped 46.55% in 2024.
- Over 5 years, Research & Development stood at $3.3 million in 2022, then soared by 110.65% to $6.9 million in 2023, then plunged by 46.55% to $3.7 million in 2024, then jumped by 82.35% to $6.7 million in 2025, then dropped by 10.73% to $6.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $6.0 million, $6.1 million, and $6.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.97 Mn |
| Jan 31, 2026 | 6.05 Mn |
| Oct 31, 2025 | 6.68 Mn |
| Jul 31, 2025 | 7.11 Mn |
| Apr 30, 2025 | 4.81 Mn |
| Jan 31, 2025 | 5.68 Mn |
| Oct 31, 2024 | 3.67 Mn |
| Jul 31, 2024 | 4.41 Mn |
| Apr 30, 2024 | 7.66 Mn |
| Jan 31, 2024 | 8.26 Mn |
| Oct 31, 2023 | 6.86 Mn |
| Jul 31, 2023 | 5.17 Mn |
| Apr 30, 2023 | 3.86 Mn |
| Jan 31, 2023 | 3.05 Mn |
| Oct 31, 2022 | 3.26 Mn |
| Jul 31, 2022 | 3.17 Mn |
| Apr 30, 2022 | 2.27 Mn |
| Jan 31, 2022 | 1.71 Mn |
| Oct 31, 2021 | 875,636.00 |
| Jul 31, 2021 | 580,819.00 |